Navigation
Recherche
|
For Alzheimer’s Scientists, the Amyloid Debate Has No Easy Answers
mercredi 16 novembre 2022, 13:00 , par Wired: Cult of Mac
For years, potential therapies that attack this brain protein have failed to help patients in clinical trials. Now—surprisingly—a new drug shows promise.
https://www.wired.com/story/for-alzheimers-scientists-the-amyloid-debate-has-no-easy-answers/
|
59 sources (15 en français)
Date Actuelle
dim. 28 avril - 06:02 CEST
|